EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTEN‐AKT pathway attenuates apoptosis and adverse remodeling in ponatinib‐induced skeletal muscle toxicity following BMP‐7 treatment

Ayushi Srivastava, Dinender K Singla iD

Physiological Reports · 2023

DOI: 10.14814/phy2.15629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Ayushi Srivastava und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Sarcopenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine kinase inhibitors (TKIs) including ponatinib are commonly used to treat cancer patients. Unfortunately, TKIs induce cardiac as well as skeletal muscle dysfunction as a side effect. Therefore, detailed mechanistic studies are required to understand its pathogenesis and to develop a therapeutic treatment. The current study was undertaken to examine whether ponatinib induces apoptosis and apoptotic mechanisms both in vitro and in vivo models and furthermore to test the potential of bone morphogenetic protein 7 (BMP‐7) as a possible treatment option for its attenuation. Sol8 cells, a mouse myogenic cell line was exposed to ponatinib to generate an apoptotic cell culture model and were subsequently treated with BMP‐7 to understand its protective effects. For the in vivo model, C57BL/6J mice were administered with ponatinib to understand apoptosis, cell signaling apoptotic mechanisms, and adverse muscle remodeling and its attenuation with BMP‐7. TUNEL staining, immunohistochemistry (IHC), and real‐time polymerase chain reaction (RT‐PCR) methods were used. Our data show significantly ( p < 0.05) increased TUNEL staining, caspase‐3, BAX/Bcl2 ratio in the in vitro model. Furthermore, our in vivo muscle data show ponatinib‐induced muscle myopathy, and loss in muscle function. The observed muscle myopathy was associated with increased apoptosis, caspase‐3 staining, and BAX/Bcl‐2 ratio as confirmed with IHC and RT‐PCR. Furthermore, our data show a significant ( p < 0.05) increase in the involvement of cell signaling apoptotic regulator protein PTEN and a decrease in cell survival protein AKT. These results suggest that increased apoptosis following ponatinib treatment showed an increase in skeletal muscle remodeling, sarcopenia, and fibrosis. Furthermore, BMP‐7 treatment significantly ( p < 0.05) attenuated ponatinib‐induced apoptosis, BAX/Bcl2 ratio, decreased PTEN, and increased cell survival protein AKT, decreased adverse muscle remodeling, and improved muscle function. Overall, we provide evidence that ponatinib‐induces apoptosis leading to sarcopenia and muscle myopathy with decreased function which was attenuated by BMP‐7.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktSarcopeniaAnimalsMiceBone Morphogenetic Protein 7Caspase 3bcl-2-Associated X ProteinMice, Inbred C57BLApoptosisMuscle, SkeletalImidazolesPyridazines

Stichwörter der Autor:innen

apoptosisatrophycell deathskeletal muscle myopathytyrosine kinase inhibitor

Substanzen

Proto-Oncogene Proteins c-aktBone Morphogenetic Protein 7Caspase 3bcl-2-Associated X ProteinponatinibImidazolesPyridazines

Autor:innen und Institutionen

  • Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.

ORCID-Profile: Dinender K Singla

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Srivastava, A., & Singla, D. K. (2023). PTEN‐AKT pathway attenuates apoptosis and adverse remodeling in ponatinib‐induced skeletal muscle toxicity following BMP‐7 treatment. Physiological Reports. https://doi.org/10.14814/phy2.15629

Vancouver

Srivastava A, Singla DK. PTEN‐AKT pathway attenuates apoptosis and adverse remodeling in ponatinib‐induced skeletal muscle toxicity following BMP‐7 treatment. Physiological Reports. 2023. doi:10.14814/phy2.15629

BibTeX
@article{Srivastava2023,
  author = {Srivastava, Ayushi and Singla, Dinender K},
  title = {PTEN‐AKT pathway attenuates apoptosis and adverse remodeling in ponatinib‐induced skeletal muscle toxicity following BMP‐7 treatment},
  journal = {Physiological Reports},
  year = {2023},
  doi = {10.14814/phy2.15629}
}
Kostenlos starten →